adriamycin

adriamycin

1. 5-fluorouracil, Adriamycin(doxorubicin)and cyclophosphamide

5-氟尿嘧啶、阿霉素和环磷酰胺

2. 5-FU, Oncovin, Adriamycin, mitomycin C

5-氟脲嘧啶、长春新碱、阿霉素、丝裂霉素C

3. 5-fluorouracil, Adriamycin, mitomycin C, semustine

5-氟脲嘧啶、阿霉素、丝裂霉素C、赛氮芥

4. 5-fluorouracil, Adriamycin, mitomycin C, streptozotocin

5-氟脲嘧啶、阿霉素、丝裂霉素C、链脲霉素

5. 5-fluorouracil, Adriamycin, cyclophosphamide, and levamisole

5-氟脲嘧啶、阿霉素、环磷酰胺和左旋四嘧唑

6. 5-fluorouracil, Adriamycin(doxorubicin), and mitomycin C

5-氟脲嘧啶、阿霉素和丝裂霉素C

7. 5-fluorouracil, Adriamycin(doxorubicin), and MeCCNU(semustine)

5-氟脲嘧啶、阿霉素和赛氮芥

8. Compared with normal group, activities of LDH, AST, CK in serum and content of MDA in car-diac muscle on adriamycin group increased (P< 0.05,P< 0.001) . activities of SOD,GSH-Px decreased in cardiac muscle (P< 0.001) .

ADR组大鼠血清中LDH、AST、CK活性及心肌中MDA含量比正常对照组显著增高(P<0.05,P<0.001),而心肌中SOD、GSH-Px活性下降(P<0.001)。

9. ANO can effectively induce the apoptosis of MCF 7 adr cells and has no cross resistance to adriamycin.

ANO能够诱导MCF 7adr乳癌细胞凋亡 ,提示ANO与阿霉素之间无交叉抗药性

10. The inhibition effect on cancer cell line HO-8910 of AZT combined with adriamycin, carboplatin was stronger than that of single-drug group (P<0.01).

AZT与卡铂、阿霉素联合用药对细胞抑制作用明显增强,与AZT、卡铂、阿霉素单独用药组相比差异有显著性(P<0.01)。

11. RD/VCR cell line was cross-resistant to vincristine (VCR), adriamycin (ADM), etoposide (VP16) and actinomycin D (DAC), but not resistant to fluorouracil (5-FU) and cisplatin (DDP).

RD/VCR细胞对长春新碱、阿霉素(ADM)、鬼臼乙叉甙(VP16)和放线菌素D(DAC)交叉耐药，对氟尿嘧啶(5-FU)、顺铂 DDP）无明显耐药性。

12. tetrahydropyranyl adriamycin

THP

13. Some compounds exhibit cytotoxicity toward KB cells and P388 murine leukemia cells,and inhibitory activity against P-glycoprotein over expressing of adriamycin resistant cell line,K562/Adr cells.

一些成分在抑制KB细胞、P388白血病细胞和P-糖蛋白方面显示了较好的活性。

14. mitomycin C,5-fluorouracil, and Adriamycin(doxorubicin)

丝裂霉素C, 5-氟尿嘧啶和阿霉素

15. Keywords breast neoplasms;drug therapy;mitoxantrone;adriamycin;

乳腺肿瘤;药物疗法;米托蒽醌;阿霉素;

16. dianhydrogalactitol, Adriamycin and platinol

二去水矛醇, 阿霉素, 顺铂

17. The concentration of ADR was increased by verapamil in LoVo /Adr cell s. The potentiation folds of adriamycin an d vincristine by verapamil in LoVo /A dr cells were 8.85and 5.31,respectively.

但5mg/L维拉帕米可显著增加LoVo/Adr细胞内阿霉素的浓度,对阿霉素和长春新碱的增敏倍数分别是8.85倍和5.31倍。

18. The glomeruli were nearly normal，but the tubular enlargement was noted at4weeks and became more obvious at8weeks and16weeks after adriamycin injection.

光镜下肾小球形态基本正常，第4周开始出现肾小管扩张，第8周和第16周时肾小管扩张更加明显，如小囊状。

19. hexamethylmelamine, cyclophosphamide, Adriamycin, Platinol

六羟甲基三聚氰胺、环磷酰胺、阿霉素、顺铂

20. hexamethylmelamine, Adriamycin, methotrexate

六羟甲基三聚氰胺、阿霉素、氨甲喋呤

21. hexamethylmelamine, Adriamycin(doxorubicin), and melphalan

六羟甲基三聚氰胺、阿霉素和苯丙氨酸氮芥

22. With regard to neurotoxic effect of adriamycin, the mechanism of its action have already described.

关于阿霉素的神经毒性作用已经有各种文献描述其作用机制。

23. Keywords Chinese herbs;adriamycin;pig;hair follicle;apoptosis;

关键词猪;毛囊;阿霉素;细胞凋亡;中药;

24. Keywords Adriamycin;4-HPR;Neplasm;bladder;Apoptosis;

关键词阿霉素;4-羟苯维胺酯;肿瘤;膀胱;脱噬作用;

25. Keywords Piperazine ferulate Adriamycin nephropathy SD rat;

关键词阿魏酸哌嗪;阿霉素肾病;SD大鼠;

26. The interacting mode between adriamycin (ADM) and DNA has been studied using molecular "light switch" complex Ru(bpy)2dppx2+ as spectroscopic probe.

利用核酸分子“光开关”Ru(bpy)_2dppx~(2+)对抗癌药物阿霉素(ADM)与DNA之间的作用方式进行了研究。

27. Keywords galactosyl-HSA;orthogonal design;adriamycin;drug carrier;

半乳糖化;正交设计;阿霉素;药物载体;

28. galactosed human serum albumin adriamycin nanoparticles

半乳糖化白蛋白磁性阿霉素纳米粒

29. galactosyl adriamycin gala-HSA magnetic nanoparticles

半乳糖基白蛋白磁性阿霉素纳米粒

30. bleomycin, dacarbazine, Oncovin, prednisone, and Adriamycin

博来霉素-达卡巴嗪-长春新碱-泼尼松-阿霉素

31. bleomycin, Oncovin, Adriamycin, prednisone

博莱霉素、长春新碱、阿霉素、强的松

32. bleomycin, Adriamycin, Cytoxan, Oncovin, dexamethasone(Decadron)

博莱霉素、阿霉素、环磷酰胺、长春新碱、地塞米松

33. ftorafur, Adriamycin(doxorubicin), cyclophosphamide, and Platinol

呋喃氟脲嘧啶、阿霉素、环磷酰胺和顺铂

34. ftorafur, Adriamycin(doxorubicin), and mitomycin C

呋喃氟脲嘧啶、阿霉素和丝裂霉素

35. Cao J G,Tang X Q,Zhou H,et al.Reveral of Multidrug Resistance by neferine in adriamycin resistant human breast cancer cell line MCF7/ ADM[J].The Chinese睪erman J Clin Oncol,2004,3(2):9396.

唐小卿,曹建国,冯鉴强.甲基莲心碱对耐阿霉素人乳腺癌细胞凋亡抗性的影响[J].中国药理学通报,2003,19(4):462466.

36. tetrahydropyranyl adriamycin(THP)

四氢吡喃阿霉素

37. Prior to this, it was Adriamycin that served as the basis for treatment and remained the gold standard for a number of years.

在此之前，阿霉素是治疗肝细胞癌的基础药物，而且多年以来都是治疗的金标准。

38. In 14 adriamycin resistant patients treated with NP regimens, response rate reached 42.9%(6/14).

复治者中14例阿霉素耐药者用NP方案治疗有效率为429%(6/14)。

39. Evaluation of myocardiotoxicity on adriamycin(ADM) with SPECT cardiac blood pool imaging was presented.

定期用SPECT检测患者左心功能，评价阿霉素（ADM）对心肌的毒性作用。

40. This study was carried out to evalute the interactions of mitomycin C (MMC), adriamycin (ADM), hydroxycamptothecine(HCPT) and thiotepa(TSPA) against a human bladder cancer cell line BIU-87 by using the MTT assay in vitro.

实验采用微量细胞培养噻唑蓝显色法观察丝裂霉素C（MMC）、阿霉素（ADM）、羟基喜树碱（HCPT）和噻替派（TSPA）等药物联合应用对膀胱癌细胞株BIU－87的毒性作用。

41. The Phase III data on Adriamycin taxane combinations are more mature than those exploring the value of Epiadriamycin.

对阿霉素+紫杉类的III期临床数据要比研究表阿霉素联合化疗更加成熟。

42. The metabolic change of lipid peroxidation caused by adriamycin (ADR) and the inhibition of bimolane (AT-1727) in rats are studied.

对阿霉素诱导的大鼠脂质过氧化代谢异常以及乙双吗啉(Bimolane,AT-1727)的拮抗作用进行了研究。

43. Keywords Acute cardiotoxicity;Adriamycin;Shengmai Injection;

急性心脏毒性;阿霉素;生脉注射液;

44. HF model was made by adriamycin.

慢性心衰模型由阿霉素制成。

45. Abstract： Objective To study the inhibitory mechanism of oral adriamycin magnetic fluid combined with extracorporeal magnetic field therapy for implanted gastric tumor in rats.

摘 要： 目的 探讨阿霉素磁液经消化道给药后，联合外磁场对鼠种植性胃肿瘤的靶向治疗作用机制。

46. Abstract Objective ：To observe the effect of cisplatin, taxol and adriamycin on in vitro growth as well as the nature of cell death of human ovarian cancer cell line OVCAR-3.

摘要 目的 ：观察抗卵巢癌药物顺铂、紫杉醇和阿霉素对卵巢癌细胞系OVCAR-3体外生长和生存的影响并分析由它们所致的细胞死亡性质。

47. Objective To analyze of efficacy of combination of polarized solution of Ka and Mg with Betaloc for treatment of cardiac muscle toxicity caused by Adriamycin.

摘要目的分析倍他洛克加钾镁极化液预防阿霉素的心脏毒性的效果。

48. Objective: To explore the synergism of 4-HPR and adriamycin on the inhibiting growth and inducing apoptosis of human urinary bladder cancer cell line (T24).

摘要目的：观察4-羟苯维胺脂(4-HPR)联合阿黴素对人源性膀胱移行细胞癌细胞株T24的生长抑制和凋亡诱导作用，探讨两者是否存在协同作用。

49. Abstract: Objective To study the assembly and release of adriamycin in vitro using magnetic thermosensitive liposomes treated with magnetic field and pyrogenation.

文章摘要: 目的：探讨磁场和加热作用下磁性热敏阿霉素脂质体在体外的聚集及释药情况。

50. NACT group received two courses of cyclophaosphaminde,mitoxantrone,5-fluorouracil(CMF)or cyclophaosphaminde,adriamycin,5-fluorouracil(CAF)prior to operation and the control group re-ceived no any anticancer therapy.

新辅助化疗组术前接受CMF或CAF方案化疗2个疗程,对照组术前不接受任何抗肿瘤治疗。

51. Methods:5.5 mg/kg of Adriamycin was intravenously used to establish rats models with minimal change nephropathy (MCD) and these AN rats were treated with Prednisone in Group C and with Prednisone plus Shenkangling decoction in Group D.

方法 :用阿霉素 (ADR) 5 .5mg/kg诱导大鼠类似于人类微小病变 (MCD)型肾病模型 ,用泼尼松 (C组 )、泼尼松 +肾康灵 (D组 )治疗 ,并设对照组。

52. Methods Flow cytometry(FCM) and electromicroscope were used to observed the morphological changes of drug resistant HCC cell expose to Isatis tinctoria L combination acid in BEL 7404/ADM(adriamycin) animal model.

方法 利用已建立的人耐药肝癌BEL 74 0 4 /ADM动物模型 ,应用FCM、透射电子显微镜等方法观察板蓝根组酸在体内对耐药肝癌细胞的形态学特征变化。

53. Methods The pure New Zealand rabbits were assigned randomly to adriamycin (ADR) group(n=9),control group(n=9) and ADR+Tau group (n=8).

方法 新西兰纯种兔 2 6只 ,随机分成对照组 (NS组 )、阿霉素 (ADR)组和ADR加牛磺酸 (Tau)组。

54. Methods A549 cells were treated with adriamycin (ADM).

方法 采用阿霉素诱导A549使其耐药。

55. METHODS: An adriamycin-resistant human gastric glandular carcinoma cell line (SGC7901/ADM) was established in vitro by gradually increased concentration of adriamycin(ADM) in the culture medium.

方法:以人胃腺癌细胞株 SGC7901 为研究对象,用阿霉素(adriamycin,ADM)浓度梯度递增诱导法,建立 SGC7901/ADM 耐药模型。

56. Method:56 cases of senior primary trigeminal neuralgia Selected andtreated by peripheral nerve branch injection with adriamycin.

方法:对56例老年原发性三叉神经痛患者进行外周神经分支注射阿霉素治疗,1年后观察疗效。

57. Methods:An ADM-resistant human colon carcinoma cell line SW480/ADM was induced by continuously exposing human colon carcinoma cell line SW480 to gradually increasing doses of Adriamycin(ADM).

方法:应用人结肠癌细胞系SW480，以递增阿霉素（ADM）浓度的方法，体外连续培养建成一株SW480/ADM。观察该细胞生长规律。

58. METHODS They were compared that the rates of apoptosis in human breast cancer cell line MCF 7/ADR which were reistant to adriamycin(Dox) and their parental sensitive cell line MCF 7 induced by Dox in the presence or absence of TTD.

方法MDR细胞株MCF－7/Adr与其相应的敏感株MCF－7进行对比研究。 比较粉防己碱对阿霉素（Dox）诱导MDR细胞及其相应的敏感株的凋亡作用。

59. Methods The clinical data of 68 cases with the advanced NSCLC treated with MVP(mitomycinc plus vindesine plus cisplatin) and CAP (cyclophosphamide plus adriamycin plus cisplatin) were analysed.

方法分析MVP(丝裂霉素、长春花碱酰胺、顺铂)方案及CAP(环磷酰胺、阿霉素、顺铂)方案治疗68例NSCLC的临床资料。

60. Methods Forty pure-bred New Zealand rabbits inoculated with tongue squamous cell carcinoma were randomized into adriamycin group and adriamycin nanometer particles group,20 animals each.

方法将40只荷舌癌的纯种新西兰白兔随机分成阿霉素纳米微粒组和阿霉素组,每组20只,以超选择性舌动脉插管分别注射阿霉素和阿霉素纳米微粒。

61. Methods The working concentration of adriamycin against K562 was determined by MTT assay.

方法采用MTT法确定阿霉素的工作浓度,以该浓度进行化疗或与热疗的联合,选择温度40℃及42℃,体外作用于K562。

62. Methods: In a clinical randomized controlled cross-over trial, 24 patients (All treated with regimens containing cisplatin or adriamycin or theprubicin) were randomized into two groups.

方法：24例均接受含顺铂或阿霉素或吡喃阿霉素的联合化疗者随机分为两组，采用双盲法随机双交叉设计，于每组化疗两个周期中交叉用药。

63. MethodsSprague-Dawley rats were administered adriamycin intraperitoneally to develop DCM.

方法：腹腔注射阿霉素建立大鼠DCM模型。

64. Methods Rat C6 glioma cell line was exposed in vitro to adriamycin assisted with X radiation.Cell apoptosis was ascertained by cell morphology and DNA fragment analysis study.

方法：通过光镜、电镜、DNA断裂分析，进行多柔比星X射线联合诱导C6胶质瘤细胞凋亡研究。

65. Methods: The effect of gastric juice, hydrocholoric acid and adriamycin on apoptosis of human bladder cancer cell line BIU-87 were observed by HE, fluorescence, DNA electrophoresis and flow cytometry.

方法：采用HE染色、荧光染色、DNA电泳、流式细胞术等技术，观察了胃液、稀盐酸、阿黴素对膀胱癌细胞系BIU-87细胞凋亡的影响。

66. Either Taxol or Taxotere can also be combined with Adriamycin (chemical name: doxorubicin).

无论是紫杉烷还是泰索帝，都可以与阿霉素联合使用。

67. The protective effect of selenium (So) on the subacute cardiomyopathy was investigated in the mouse given a single dose of adriamycin (ADR 17. 5mg/kg ip).

本文以1次剂量阿霉素(ADR 17.5mg/kg ip)引起小鼠亚急性心肌早期病变,探讨硒的保护作用。

68. This paper introduces mechanism and feature of the toxicity in sensory ganglion of adriamycin as well as clinical application.

本文将重点介绍阿霉素对感觉神经节细胞的毒性机制、特点及其临床应用。

69. This article put emphasis on the mechanism of adriamycin effects on trigeminal ganglion and its advance of experimental study.

本文重点介绍阿霉素对于半月神经节的作用机制及实验研究进展。

70. This study was to investigate the adriamycin (ADR)-resistance of thermotolerant hepatocarcinoma cell line HepG2/thermotolerance and the effect of neferine (Nef) on the ADR-resistance of HepG2/thermotolerance cells.

本研究探讨耐热肝癌细胞能否对阿霉素(adriamycin,ADR)产生耐受性,以及甲基莲心碱(neferine,Nef)能否逆转耐热肝癌细胞的阿霉素耐药性。

71. The purpose of this experiment is to explore whether or not Adriamycin inhibits MEC cells by apoptosis so as to make further use of Adriamycin in the treatment of MEC.

本研究的目的在于探明阿霉素作用于细胞后，是否通过诱导粘液表皮样癌细胞凋亡而抑制肿瘤细胞生长，以进一步发挥阿霉素在治疗粘液表皮样癌中的作用。

72. The aim of this study was to ex amine the reversal effects of high intensity focused ultrasound (HIFU) and co-a dministration with Adriamycin (ADM) on multidrug resistance (MDR) in HepG2/Adm c ells, and to investigate its mechanism.

本研究评价高强度聚焦超声及其联合阿霉素(Adriamycin,ADM)对人肝癌多药耐药细胞株HepG2/Adm的效应,并探讨其作用机制。

73. Methods: HL-60/ADM cells with multidrug resistance induced by adriamycin (ADM) were experimental group, and the sensitive HL-60 cells were used as control group.

材料方法 本研究采用阿霉素诱导产生耐药的HL-60/ADM细胞系为实验对象，对化疗药物敏感的HL-60细胞系为对照。

74. adriamycin and cyclophosphamide methotrexate

氨甲蝶呤, 阿霉素和环磷酰胺

75. nitrogen mustard, Adriamycin(doxorubicin), and CCNU(lomustine)

氮芥, 阿霉素, 环己亚硝脲

76. Lisinopril， prednisone and all-trans retinoic acid (ATRA) were administered once a day to the adriamycin-induced nephrotic rats at the first day after adriamycin injection respectively.

注射阿霉素后次日分别给予利生普利、泼尼松以及全反式维甲酸(ATRA)干预蛋白尿。

77. Expression of Bcl-2 protein and P-gp, Caspase-3 activity and cellular adriamycin (ADM) were measured with flow cytomery (FCM).

流式细胞术(FCM)测定K562/ADM细胞Bcl-2蛋白和P-gp表达水平、Caspase-3活性和细胞内阿霉素(ADM)含量;

78. CCNU(lomustine), isophosphamide, and Adriamycin(doxorubicin)

环己亚硝脲, 异磷酸胺, 阿霉素

79. CCNU, Adriamycin, bleomycin, streptozotocin

环己亚硝脲, 阿霉素, 博莱霉素, 链脲菌素

80. CCNU(lomustine), Adriamycin(doxorubicin), and Velban(vinblastine)

环己亚硝脲, 阿霉素和长春花碱